Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
Go back to Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress| (NASDAQ: COAG) | Delayed: 41.22 +0.25 (0.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.97 | 52 Week High | $ | |||
| Open | $41.23 | 52 Week Low | $ | |||
| Day High | $43.47 | P/E | N/A | |||
| Day Low | $40.42 | EPS | $ | |||
| Volume | 429,043 | |||||
